Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Clin Trials. 2021 Jul 3;18(5):582–593. doi: 10.1177/17407745211028581

Table 1.

Summary of simulation study.

Analysis methods were evaluated using the results from 1000 simulated data sets, each of which was analyzed using the analysis methods applied to the simulated number of episodesa for each of the villages in the two treatment conditions. Simulation details and model code are given in the supplementary material. Any abbreviations that have been used for ease of readability in all following tables and figures have been defined here.

Scenarios simulated

 Treatment effect Rate ratio: eβ1 = 1.0, 0.9, 0.8, 0.7, 0.6, 0.6191.088
 Number of clusters 6, 10, 14, 18
 Effect of year α: Year 1 = e0.0843–0.1054 year 2 = e 0.0843 – 0.1054
 One rainy season Separate analyses of the first- and second-year results
 Two rainy seasons (parallel) Analysis of combined Year 1 and Year 2 data
 Two rainy seasons (crossover) Analysis of data from a crossover design

Metrics evaluated

 Bias Difference between the estimated and true value for β1
 Coverage Proportion of 95% confidence interval that includes β1
 Power Probability of rejecting the null hypothesis: 1 = 1.0

Summary of models compared

Category Name Method of model fitting

MM Mixed models PL: Pseudo-likelihood
PLKR: Pseudo-likelihood, Kenward-Roger correction
ML: Laplace: Laplace approximation to the likelihood
ML: AGQ-10: Adaptive Gaussian quadrature
GEEs Generalized estimating equations
Using model-based standard error
Using empirical standard error
Using MBN correction, proposed by Morel, Bokossa, and Neerchal
Using FG correction, proposed by Fay and Graubard
Cluster-level analyses
Unweighted t-test
Size weighted
Variance weighted
Adjusted residual
a

The number of episodes was simulated to follow a Poisson distribution with mean rate λijk denoting the rate with treatment i = (0,1) in village j = 1 ,…, 7 and subject k = 1 ,…, Nij; X1 = 0 satisfying log(λijk) = α + β1Xi + β2Xijk + uij, where Xi = 0 (control) or Xi = 1 (Ivermectin), and Xijk = 0 (female) or Xijk = 1 (male) and α = intercept; β1 = log of the rate ratio treatment versus control; β2 = log of the rate ratio male versus females; and uij = random village effect: uijN(0, 0.05 or 0.10).